Xyntha 250 IU Powder and Solvent for Solution for Injection

Manufacturer
WYETH FARMA, S.A(SPAIN)

Registraction Number
MAL20091989AZ

Content:
Xyntha 250 IU Powder and Solvent for Solution for Injection contains Moroctocog alfa, a recombinant antihemophilic factor (factor VIII). It is used to control and prevent bleeding episodes in patients with Hemophilia A.
Indications:

• Control and prevention of bleeding episodes in patients with Hemophilia A.
• Prophylaxis to reduce the frequency of bleeding episodes.
• Surgical prophylaxis in patients with Hemophilia A.

1. Reconstitution: Reconstitute the powder with the provided solvent for intravenous injection.
2. Dosage: The dosage depends on the severity of the bleeding, the location and extent of bleeding, and the patient's clinical condition. It is crucial to follow the dosage instructions provided by your healthcare provider.
3. Administration: Administer the reconstituted solution intravenously under the supervision of a healthcare professional experienced in the treatment of Hemophilia A.
4. Monitoring: Regularly monitor factor VIII levels and adjust the dosage as needed.